Management of Hypothyroidism with Elevated TSH and Normal Free T4

Initial Assessment and Diagnosis

The patient has subclinical hypothyroidism with elevated TSH and normal Free T4, with TSH levels between 4.5-10 mIU/L, and treatment decisions should be based on presence of symptoms, cardiovascular risk factors, and patient preference 1, 2
Thyroid function tests, including TSH, Free T4, and Free T3, should be used to diagnose and monitor hypothyroidism, with normal ranges for TSH (0.450-4.500 uIU/mL), Free T4 (0.82-1.77 ng/dL), and Free T3 (2.0-4.4 pg/mL) 1

For patients with elevated TSH and normal Free T4, levothyroxine therapy is indicated, particularly when TSH is persistently >10 mIU/L or when symptoms are present, with a starting dose calculated based on patient characteristics, such as 1.6 mcg/kg/day for healthy adults under 70 2
The American College of Clinical Oncology recommends that treatment decisions be based on presence of symptoms, cardiovascular risk factors, and patient preference, with a goal of achieving TSH within the normal reference range (0.450-4.500 uIU/mL) 2

Once TSH normalizes, continue monitoring every 6-12 months or as indicated by symptom changes, with Free T4 levels used to interpret abnormal TSH levels during therapy 2, 1
The peak therapeutic effect of levothyroxine may take 4-6 weeks to attain, and dosage adjustments should be made every 4-6 weeks until the patient is euthyroid and TSH is within the reference range 1, 2

Failing to recheck thyroid function tests 6-8 weeks after initiating therapy or changing dose, which can lead to overtreatment or undertreatment, and overlooking medication interactions that can affect levothyroxine absorption 2, 1